INTERNATIONAL PATENT: STAIDSON BIOPHARMA INC. FILES APPLICATION FOR "ANTI-PD-L1 AND IL-15 PRODRUG BIFUNCTIONAL PROTEIN AND USES THEREOF"

GENEVA, Aug. 12 -- STAIDSON BIOPHARMA INC. (2600 Hilltop DriveRichmond, California 94806) filed a patent application (PCT/US2025/012251) for "ANTI-PD-L1 AND IL-15 PRODRUG BIFUNCTIONAL PROTEIN AND USES THEREOF" on Jan 18, 2025. With publication no. WO/2025/165594, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHAI, Wenwu (5443 Brookwood LaneRichmond, California 94803), YIN, Yong (1663 Northshore DriveRichmond, California 94804)

Abstract: The present application provides IL- 15 prodrugs comprising the masking polypepti...